Todd Patrick is the founder of Armata Pharmaceuticals. Armata Pharmaceuticals has raised $25M in total funding. Latest round: Grant. Backed by Innoviva, Inc..
Todd R. Patrick was the Chief Executive Officer of Armata Pharmaceuticals, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections. During his tenure, Armata made progress including the merger of AmpliPhi Biosciences and C3J Therapeutics and the initiation of its first clinical trial for AP-PA02. In January 2020, Armata Pharmaceuticals announced a $25 million strategic investment from Innoviva, Inc. to support the advancement of its bacteriophage development programs.
Full founder directory · Investor directory · Company funding database · Fundraising library